GENOMIC EXPRESSION INC
RNA analysis platform for disease detection, health monitoring, and therapeutic design
- Sector
- Biotech
- Headquarters
- NEW YORK, NY
- Founded
- 2009
- Latest Form D
- $200K, Jun 2014
- Total capital
- $881K
- Federal grants
- $340K
- 1 award
- Rank in peer group#24 of 28
- Private capital raised
- $200K
- 1 Form D · last Jun 2014
- 148 months since last filing
- Federal contracts
- $340K
- 1 award · Health and Human S
- Rank in Biotech#251 of 4373
- Granted patents
- 0
- 3 pending
Capital timeline
Latest events
- Federal contractHealth and Human S · EO 14042 SBIR Topic 425 Phase I: Posture Analysis Through Machine Learning (pathml)$340K
- Private capital raisedForm D · SEC · 1st filing$200K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 28 peers
Line = medianBiotech · Instrument
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Geoffrey FolkerthExecutive OfficerNamed in SEC Form D filings
- Gitte PedersenExecutive Officer, DirectorNamed in SEC Form D filings
- Jesper ZeuthenExecutive OfficerNamed in SEC Form D filings
- Morten PedersenExecutive Officer, DirectorNamed in SEC Form D filings
- Tanya KaniganExecutive OfficerNamed in SEC Form D filings
- Yota PalliDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 3- PendingIdentification And Design Of Cancer Therapies Based On Rna SequencingUSPTOApplication 18503844
- PendingIdentification And Design Of Cancer Therapies Based On Rna SequencingUSPTOApplication PCTUS2022028582
- PendingIdentification And Design Of Cancer Therapies Based On Rna SequencingUSPTOApplication 63187210
Related companies, and why
- CLOVERLEAF BIO, INC.Similar federal contract value in Biotech · $355K in contracts
- MATRISOME BIO, INC.Similar federal contract value in Biotech · $354K in contracts
- Longevity Biotech, IncSimilar federal contract value in Biotech · $348K in contracts
- AFASCI, INC.Similar federal contract value in Biotech · $339K in contracts
- Telesis Bio Inc.Similar federal contract value in Biotech · $337K in contracts
- QUALITY BIOLOGICAL, INC.Similar federal contract value in Biotech · $336K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .